Hello, everyone, and how are you today? Sunny skies are emerging here on the Pharmalot corporate campus, where we are brewing a delicious cup of stimulation - Rain Forest Nut, in this case - and hustling to tend to various matters as another busy day lies ahead. We trust you can relate. So let us not dilly or dally. A few tidbits can be found below. We hope you have a productive day and conquer the world. Meanwhile, do stay in touch...
J&J Has Enough Doxil For Patients On Waiting List (Dow Jones)
J&J Memo Told Reps To Push Risperdal For Kids (Bloomberg News)
EMA OKs Genzyme Fabrazyme Plant In Massachusetts (Dow Jones)
J&J Opens Biotech Startup Center (Xconomy)
Columbia Labs Gel To Reduce Pre-Terms Births Is Not Effective (Bloomberg News)
FDA Approves BTG Drug For Cancer Toxicity (Reuters)
Bayer Colorectal Cancer Drug Improves Survival: Study (Dow Jones)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr